Glutathione (GSH) is a tripeptide — glycine, cysteine, glutamate — that functions as the body's primary intracellular antioxidant and detoxification molecule. It is produced in every cell, with the highest concentrations in the liver. Its functions are broad and clinically significant: direct antioxidant neutralization of ROS; recycling oxidized vitamin C and E; Phase II liver detoxification (conjugating toxins, heavy metals, carcinogens for excretion — the mechanism behind acetaminophen toxicity, which depletes hepatic glutathione); and T-cell and NK cell immune function.
Why Injectable Exists: The Oral Absorption Problem
Oral glutathione supplements have a bioavailability problem — the tripeptide is largely broken down by digestive enzymes before absorption. Studies on oral glutathione show variable and often modest increases in blood levels. Parenteral (injectable) glutathione bypasses GI breakdown entirely, entering systemic circulation at full concentration with measurably higher plasma levels than equivalent oral doses. This is the pharmacokinetic rationale for injectable therapy — not simply marketing differentiation.
Precursor supplementation (N-acetylcysteine/NAC — provides the rate-limiting cysteine substrate) is an alternative that works well orally; NAC robustly increases intracellular glutathione and may be discussed as a complement to injectable therapy.
What the Evidence Shows
- Liver disease and acetaminophen toxicity: IV glutathione (via N-acetylcysteine) is the backbone of acetaminophen overdose management — the strongest clinical evidence for parenteral glutathione's hepatoprotective role
- Parkinson's disease: IV glutathione has FDA-approved limited use for reducing Parkinson's symptoms; depleted substantia nigra glutathione is documented in Parkinson's patients
- Aging and immune function: Glutathione levels decline with age; lower lymphocyte glutathione correlates with reduced immune function; supplementation studies show improvements in immune activation markers in older adults
- Athletic recovery: Small RCTs suggest injectable glutathione reduces exercise-induced oxidative stress markers; effect sizes are modest
- Skin health: Glutathione inhibits tyrosinase (melanin synthesis); studied for skin evenness in small trials. FDA has not approved any glutathione product for skin lightening.
- General wellness/energy: Primarily observational and anecdotal. Large RCTs for general energy in healthy adults don't yet exist. Patients report meaningful subjective benefit.
Safety Profile
- Injection-site reactions: Mild redness/discomfort at injection site — common, transient
- Hypersensitivity reactions: Higher rate among compounded injectables than most. Hives, flushing, and rare anaphylaxis reported. Call 911 immediately for throat tightening, widespread hives, or breathing difficulty after any glutathione injection.
- Thyroid function: Some literature suggests high-dose glutathione can affect thyroid function — disclose thyroid disease before starting
- Avoid in active malignancy: Glutathione's antioxidant effects may theoretically protect cancer cells — sufficient reason to avoid in active cancer
Glutathione injectable, when prescribed at YourMD, is a compounded preparation, not FDA-approved, prepared by a licensed 503A compounding pharmacy (for example Hallandale Pharmacy or Valiant Compounding Pharmacy); the dispensing pharmacy is named on your prescription label. Subcutaneous home administration following a physician-provided sterile injection protocol; priced at your consult.
Related: NAD+ Injections: What the Evidence Shows · Sermorelin vs HGH